Detalhe da pesquisa
1.
Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy.
Breast Cancer Res Treat
; 179(1): 67-77, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562570
2.
Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy.
Breast Cancer Res Treat
; 179(3): 769, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31734822
3.
G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer.
Breast Cancer Res Treat
; 180(3): 635-646, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130619
4.
Lateral hypothalamic proenkephalin neurons drive threat-induced overeating associated with a negative emotional state.
Nat Commun
; 14(1): 6875, 2023 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37898655
5.
Early adversity promotes binge-like eating habits by remodeling a leptin-responsive lateral hypothalamus-brainstem pathway.
Nat Neurosci
; 26(1): 79-91, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36510113
6.
Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant.
Sci Adv
; 9(20): eadg1448, 2023 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37205758
7.
Belatacept-Based Maintenance Immunosuppression Controls the Post-Transplant Humoral Immune Response in Highly Sensitized Nonhuman Primates.
Kidney360
; 3(12): 2116-2130, 2022 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36591367
8.
Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model.
Front Immunol
; 12: 660900, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34149698
9.
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma.
J Clin Invest
; 131(23)2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637400
10.
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer.
Cell Rep
; 29(4): 889-903.e10, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31644911